https://charts.traderzeitung.de/phases/US45779A8466
string(1413) "{"isin":"US45779A8466","name":"InspireMD Inc","stock_id_xnas":22560688,"stock_id_xnys":null,"generated_at":"2026-09-24 01:31:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":0.783,"close_at":"2026-09-21 15:28:00","complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.756,"close_at":"2026-09-21 21:41:00","complete":true,"perf_pct":-3.4483},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.761,"close_at":"2026-09-22 21:56:00","complete":true,"perf_pct":0.6614},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":0.743,"close_at":"2026-09-23 21:58:00","complete":true,"perf_pct":-2.3653},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":false,"perf_pct":null}]}]}"
InspireMD

InspireMD Aktie News & Nachrichten

[WKN: A3CMP3 | Symbol: NSPR]
Realtimekurs
   
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.
Vorbörsliche Indikationen
Regulärer Handel
Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über InspireMD gefunden werden.

MT Newswires 24.07.2026 12:10 Uhr

InspireMD erhält Nasdaq-Mindestgebotspreis-Warnung

06:09 AM EDT, 07/24/2026 (MT Newswires) -- InspireMD (NSPR) teilte am Donnerstag mit, dass das Unternehmen eine Mängelrüge von der Nasdaq (NDAQ) erhal